Avion Wealth’s Syndax Pharmaceuticals SNDX Stock Holding History

Avion Wealth’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	100	–	–	﹤0.01%	1124
2026 Q1	$2K	Hold	100	–	–	﹤0.01%	914
2025 Q4	$2K	Hold	100	–	–	﹤0.01%	924
2025 Q3	$1K	Hold	100	–	–	﹤0.01%	1101
2025 Q2	$0	Hold	100	–	–	﹤0.01%	1577
2025 Q1	$1K	Hold	100	–	–	﹤0.01%	925
2024 Q4	$1K	Hold	100	–	–	﹤0.01%	923
2024 Q3	$1K	Buy	+100	New	+$2.07K	﹤0.01%	903

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Avion Wealth's SNDX Position: Q2 2026 in Review

Avion Wealth held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 100 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Avion Wealth first reported a position in SNDX in Q3 2024 and has held it in 8 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Avion Wealth held 100 shares of Syndax Pharmaceuticals worth $2K as of Q2 2026.
Avion Wealth left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
Syndax Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1124 holding.
Avion Wealth first reported a position in Syndax Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.